Načítá se...
Glutamatergic Neurometabolites in Clozapine-Responsive and -Resistant Schizophrenia
BACKGROUND: According to the current schizophrenia treatment guidelines, 3 levels of responsiveness to antipsychotic medication exist: those who respond to first-line antipsychotics, those with treatment-resistant schizophrenia who respond to clozapine, and those with clozapine-resistant or ultra-tr...
Uloženo v:
| Vydáno v: | Int J Neuropsychopharmacol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4438552/ https://ncbi.nlm.nih.gov/pubmed/25603859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyu117 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|